Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$32.69 - $47.91 $7.65 Million - $11.2 Million
-233,933 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$37.1 - $50.11 $7.02 Million - $9.48 Million
189,092 Added 421.69%
233,933 $9.84 Million
Q3 2018

Nov 14, 2018

SELL
$36.35 - $55.2 $13.4 Million - $20.3 Million
-368,030 Reduced 89.14%
44,841 $2.24 Million
Q2 2018

Aug 14, 2018

SELL
$33.85 - $50.65 $35.4 Million - $53 Million
-1,046,201 Reduced 71.7%
412,871 $15.8 Million
Q1 2018

May 15, 2018

BUY
$32.45 - $54.7 $17 Million - $28.6 Million
522,909 Added 55.86%
1,459,072 $58.5 Million
Q4 2017

Feb 14, 2018

BUY
$21.8 - $39.35 $8.11 Million - $14.6 Million
371,915 Added 65.91%
936,163 $32.9 Million
Q3 2017

Nov 14, 2017

BUY
$16.4 - $25.05 $9.25 Million - $14.1 Million
564,248
564,248 $12.3 Million

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.24B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.